Patel Mahesh V. 4/A
4/A · Lipocine Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4/AAmended
Lipocine Inc.LPCN
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-23$4.80/sh+10,320$49,536→ 132,688 totalExercise: $4.80From: 2025-12-23Exp: 2034-12-23→ Common Stock (10,320 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.